WordNet

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 鉄欠乏性貧血を有する成人の治療 treatment of the adult with iron deficiency anemia
2. 非透析患者、腹膜透析患者、および家庭での血液透析を行う患者における鉄バランス iron balance in nondialysis peritoneal dialysis and home hemodialysis patients
3. 血液透析患者における鉄剤の使用 use of iron preparations in hemodialysis patients
4. 幼児および若齢小児における鉄欠乏：治療 iron deficiency in infants and young children treatment
5. 貧血と腎移植レシピエント anemia and the renal transplant recipient

Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients.

Airy M1, Mandayam S1, Mitani AA2, Chang TI3, Ding VY4, Brookhart MA5, Goldstein BA6, Winkelmayer WC7.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.Nephrol Dial Transplant.2015 Aug 26. pii: gfv305. [Epub ahead of print]
BACKGROUND: Ferumoxytol was first approved for clinical use in 2009 solely based on data from trial comparisons with oral iron on biochemical anemia efficacy end points. To compare the rates of important patient outcomes (infection, cardiovascular events and death) between facilities predominantly
PMID 26311216

Effects of carnitine on oxidative stress response to intravenous iron administration to patients with CKD: impact of haptoglobin phenotype.

Armaly Z1,2, Abd El Qader A3,4, Jabbour A5,6, Hassan K7, Ramadan R8, Bowirrat A9,10, Bisharat B11,12.
BMC nephrology.BMC Nephrol.2015 Aug 13;16:135. doi: 10.1186/s12882-015-0119-0.
BACKGROUND: Anemia is a common disorder in CKD patients. It is largely attributed to decreased erythropoietin (EPO) production and iron deficiency. Therefore, besides EPO, therapy includes iron replenishment. However, the latter induces oxidative stress. Haptoglobin (Hp) protein is the main line of
PMID 26268514

Physico-chemical properties of the new generation IV iron preparations ferumoxytol, iron isomaltoside 1000 and ferric carboxymaltose.

Neiser S1, Rentsch D, Dippon U, Kappler A, Weidler PG, Göttlicher J, Steininger R, Wilhelm M, Braitsch M, Funk F, Philipp E, Burckhardt S.
Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine.Biometals.2015 Aug;28(4):615-35. doi: 10.1007/s10534-015-9845-9. Epub 2015 Mar 24.
The advantage of the new generation IV iron preparations ferric carboxymaltose (FCM), ferumoxytol (FMX), and iron isomaltoside 1000 (IIM) is that they can be administered in relatively high doses in a short period of time. We investigated the physico-chemical properties of these preparations and com
PMID 25801756

園田司,安藤直行,藤平善久
表面技術 = The journal of the Surface Finishing Society of Japan 60(10), 676-677, 2009-10-01
NAID 10025396209

園田司,安藤直行,藤平善久
表面技術 = The journal of the Surface Finishing Society of Japan 59(10), 701-702, 2008-10-01
NAID 10024328779

堀田慎一,菅野正治,本間英夫
表面技術 44(3), 217-220, 1993
… The bath was less stable than an electroless nickel bath due to the formation of ferrous or ferric hydroxide precipitates. … Gluconate ion was one of the best complexing agents for stabilizing the bath.L-ascorbic acid is a mild reducing agent and inhibited the formation of ferric ions in the bath. …
NAID 130001072456